SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 20, 2015
OptimizeRx Corporation
(Exact name of registrant as specified in its charter)
| Nevada | 000-53605 | 26-1265381 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
| 400 Water Street, Suite 200, Rochester, MI | 48307 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: 248-651-6568
___________________________________________________
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
SECTION 7 – Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure
On January 20, 2015, we issued a press release concerning the presentation given by David Harrell, our Chief Executive Officer, at the Noble Financial Capital Markets Eleventh Annual Equity Conference, and his statement concerning our estimated revenues for 2014. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The information in Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
SECTION 9 – Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
| 99.1 | Press release, dated January 12, 2015 |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OptimizeRx Corporation
| /s/ Doug Baker | |
| Doug Baker Chief Financial Officer |
|
| Date: January 21, 2015 |
3
Exhibit 99.1
OptimizeRx Corporation Presents at Noble Financial Capital Markets Equity Conference
ROCHESTER, MI — 1/20/15 — OptimizeRx Corporation (OTCQB: OPRX) announced that David Harrell, its Chief Executive Officer, presented at the Noble Financial Capital Markets Eleventh Annual Equity Conference at Club Med in Sandpiper Bay, Florida on Monday, January 19, 2015.
The presentation covered the Company’s continued growth and the escalation of the emerging electronic co-pay coupon market within the $360 Billion U.S. pharmaceutical sector. During the presentation, the Company announced that its 2014 sales are estimated to be approximately $6.3 million.
The webcast and presentation is archived on our website at http://www.optimizerxcorp.com/investors.
About OptimizeRx Corp
OPTIMIZERx Corp. (OTCQB: OPRX) provides unique consumer and
physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical
and healthcare companies more effective ways to expand patient awareness, access and adherence to their medications. For more
information, please go to www.optimizerxcorp.com or www.samplemd.com.
About Noble Financial
Noble Financial Capital Markets was established in 1984. Noble Financial is an equity research driven, full-service, investment banking boutique focused on life sciences, technology, energy and media, emerging growth, companies. The Company has offices in New York, Boston, Los Angeles, and Boca Raton, FL. In addition to non-deal road shows and sector specific conferences throughout the year, Noble Financial hosts its large format annual equity conference in January in South Florida featuring 120-150 presenting companies from across North America and total attendance close to 600. For more information go to www.noblefcm.com.
'SAFE HARBOR'
This press release contains forward-looking statements within
the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended.
These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking'
and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company
undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future
events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted,
or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying
the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not
limited to, the effect of government regulation, competition and other material risks.
Contact:
OptimizeRx
Doug Baker
dbaker@samplemd.com
248-651-6568 x807